GARY FRICK: Open Payments
NPI 1962548552 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,458 in 104 payments from 17 companies in 2025. Trend: 2023 $2,000 · 2024 $2,532 · 2025 $2,458
Food & beverage: $2,458
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $416 |
| ABBVIE INC. | 15 | $411 |
| Otsuka America Pharmaceutical, Inc. | 15 | $317 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $253 |
| Vanda Pharmaceuticals Inc. | 7 | $226 |
| Neurocrine BioSciences, Inc. | 14 | $224 |
| Janssen Pharmaceuticals, Inc | 6 | $140 |
| Axsome Therapeutics, Inc. | 5 | $138 |
| Lundbeck LLC | 5 | $99 |
| Amgen Inc. | 1 | $69 |
Products named: COBENFY, VRAYLAR, REXULTI, CAPLYTA, INGREZZA, FANAPT, Auvelity, SPRAVATO.
Industry payments across FL — which companies pay providers there.
